Trial Profile
Predictors of pirfenidone effect in patients with idiopathic pulmonary fibrosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2014
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 25 Sep 2014 New trial record